The law offices of frank r. cruz announces investigation of amryt pharma plc (amyt) on behalf of investors

Los angeles--(business wire)--the law offices of frank r. cruz announces an investigation of amryt pharma plc (“amryt ” or the “company”) (nasdaq: amyt) on behalf of investors concerning the company's possible violations of federal securities laws. if you are a shareholder who suffered a loss, click here to participate. on february 28, 2022, amryt disclosed receipt of a complete response letter (“crl”) from the u.s. food and drug administration (“fda”) stating that the company's new drug applic
AMYT Ratings Summary
AMYT Quant Ranking